As expected, Irhom2 deletion completely displaced Zdhhc3 ablation‐triggered improvement of steatohepatitis in the context of HFHC‐induced NASH phenotype. The gene discussed is ZDHHC3; the disease is metabolic dysfunction-associated steatohepatitis.